🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Effects of Home-based Graded Repetitive Arm Supplementary Program Group on Stroke.

RecruitingNAAges 20 Years - anyAllNational Taiwan University Hospital
NCT06883357 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Graded repetitive arm supplementary program (GRASP) is a self administrated, home-based rehabilitation program and has been incorporated in Canadian Stroke Best Practice Recommendations. Past studies indicated that the home-based GRASP program could facilitate the motor function and motor recovery and prevent learned nonuse of affected upper limb of stroke patients. There is lacking of research and application of the home-based GRASP program in Taiwan. Therefore, this study aims to explore the effects of the home-based GRASP program, which is mainly executed in the form of group intervention, on the affected upper limb of stroke patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age is above 20 years old. 2. Onset of first stroke complicated with hemiplegia or hemiparesis. 3. The affected upper limb remains partially voluntary movements including lifting to chest level and holding for five seconds; slight flexion and extension of wrist and hand. 4. Understanding and complying with two-steps commands. 5. Understanding the content of trial and willing to sign informed consent. Exclusion Criteria: 1. Complicating with other neurological disease. 2. Having Orthopedic diseases affecting the movements of upper limbs. 3. Having symptoms of pain to affect the movements of upper limbs. 4. Unstable vital sign or medical condition. 5. Participating another rehabilitative or drug research meanwhile. 6. Receiving botulinum toxin injection within three months.
💊

What it tests

  • Graded repetitive arm supplementary program (GRASP)
📍

Where

1 site
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy